A New Way to Study Cancer and its Treatments

This article in the Washington Post details how the NCI-MATCH research study is a prime example of a shift toward precision medicine. The trial is designed to be more efficient, faster and better able to match drugs with patients that are most likely to benefit from them.

Link to this article